Table of Contents
Advances in Endocrinology
Volume 2014, Article ID 231432, 14 pages
http://dx.doi.org/10.1155/2014/231432
Review Article

Persistent Comorbidities in Cushing’s Syndrome after Endocrine Cure

Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), Instituto de Investigación Biomédica (IIB)-Sant Pau, ISCIII, Hospital Sant Pau, Endocrinology/Medicine Department and Universitat Autònoma de Barcelona, C. S. Antoni Maria Claret no. 167, 08025 Barcelona, Spain

Received 13 February 2014; Revised 15 April 2014; Accepted 15 April 2014; Published 4 May 2014

Academic Editor: Sarantis Livadas

Copyright © 2014 Eugenia Resmini. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Arnaldi, A. Angeli, A. B. Atkinson et al., “Diagnosis and complications of Cushing's syndrome: a consensus statement,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5593–5602, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. L. K. Nieman, B. M. K. Biller, J. W. Findling et al., “The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1526–1540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Newell-Price, X. Bertagna, A. B. Grossman, and L. K. Nieman, “Cushing's syndrome,” The Lancet, vol. 367, no. 9522, pp. 1605–1617, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. F. P. Giraldi, M. Moro, and F. Cavagnini, “Gender-related differences in the presentation and course of Cushing's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1554–1558, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Newell-Price, “Cushing's syndrome,” Clinical Medicine, vol. 8, no. 2, pp. 204–208, 2008. View at Google Scholar · View at Scopus
  6. B. Catargi, V. Rigalleau, A. Poussin et al., “Occult Cushing's syndrome in type-2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5808–5813, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. O. Van Aken, A. M. Pereira, N. R. Biermasz et al., “Quality of life in patients after long-term biochemical cure of cushing's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 6, pp. 3279–3286, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Lado-Abeal, J. Rodriguez-Arnao, J. D. C. Newell-Price et al., “Menstrual abnormalities in women with cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 9, pp. 3083–3088, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Karaca, B. Acmaz, G. Acmaz et al., “Routine screening for Cushing's syndrome is not required in patients presenting with hirsutism,” European Journal of Endocrinology, vol. 168, pp. 379–384, 2013. View at Google Scholar
  10. B. M. K. Biller, A. B. Grossman, P. M. Stewart et al., “Treatment of adrenocorticotropin-dependent cushing's syndrome: a consensus statement,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 7, pp. 2454–2462, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Invitti, F. P. Giraldi, M. de Martin, and F. Cavagnini, “Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis,” Journal of Clinical Endocrinology and Metabolism, vol. 84, pp. 440–448, 1999. View at Google Scholar
  12. D. Bochicchio, M. Losa, M. Buchfelder et al., “Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 11, pp. 3114–3120, 1995. View at Google Scholar · View at Scopus
  13. N. Sonino, M. Zielezny, G. A. Fava, F. Fallo, and M. Boscaro, “Risk factors and long-term outcome in pituitary-dependent Cushing's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 7, pp. 2647–2652, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. L. B. Yap, H. E. Turner, C. B. T. Adams, and J. A. H. Wass, “Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit,” Clinical Endocrinology, vol. 56, no. 1, pp. 25–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. D. A. Rees, F. W. F. Hanna, J. S. Davies, R. G. Mills, J. Vafidis, and M. F. Scanlon, “Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission,” Clinical Endocrinology, vol. 56, no. 4, pp. 541–551, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. R. McCance, M. Besser, and A. B. Atkinson, “Assessment of cure after transsphenoidal surgery for Cushing's disease,” Clinical Endocrinology, vol. 44, no. 1, pp. 1–6, 1996. View at Google Scholar · View at Scopus
  17. E. Valassi, B. M. K. Biller, B. Swearingen et al., “Delayed remission after transsphenoidal surgery in patients with cushing's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 601–610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Terzolo, S. Bovio, G. Reimondo et al., “Subclinical Cushing's syndrome in adrenal incidentalomas,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 423–439, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. L. K. Nieman, B. M. K. Biller, J. W. Findling et al., “The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 1526–1540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Chiodini, “Diagnosis and treatment of subclinical hypercortisolism,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 5, pp. 1223–1236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. G. M. Garrapa, P. Pantanetti, G. Arnaldi, F. Mantero, and E. Faloia, “Body composition and metabolic features in women with adrenal incidentaloma or cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 11, pp. 5301–5306, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Tauchmanovà, R. Rossi, B. Biondi et al., “Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 4872–4878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Rossi, L. Tauchmanova, A. Luciano et al., “Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 4, pp. 1440–1448, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Chiodini, V. Morelli, B. Masserini et al., “Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3207–3214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Eller-Vainicher, V. Morelli, F. M. Ulivieri et al., “Bone quality as measured by trabecular bone score (TBS) in patients with adrenal incidentalomas with and without subclinical hypercortisolism,” Journal of Bone and Mineral Research, vol. 27, pp. 2223–2230, 2012. View at Google Scholar
  26. A. Toniato, I. Merante-Boschin, G. Opocher, M. R. Pelizzo, F. Schiavi, and E. Ballotta, “Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study,” Annals of Surgery, vol. 249, no. 3, pp. 388–391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Chiodini, V. Morelli, A. S. Salcuni et al., “Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2736–2745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Tsagarakis, D. Vassiliadi, and N. Thalassinos, “Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications,” Journal of Endocrinological Investigation, vol. 29, no. 5, pp. 471–482, 2006. View at Google Scholar · View at Scopus
  29. V. Morelli, G. Reimondo, R. Giordano et al., “Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study,” Journal of Clinical Endocrinology and Metabolism, vol. 99, no. 3, 2014. View at Publisher · View at Google Scholar
  30. F. Hammer and P. M. Stewart, “Cortisol metabolism in hypertension,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 20, no. 3, pp. 337–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Pecori Giraldi, P. M. Toja, M. de Martin et al., “Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure,” Hormone and Metabolic Research, vol. 39, no. 12, pp. 908–914, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Baid and L. K. Nieman, “Glucocorticoid excess and hypertension,” Current Hypertension Reports, vol. 6, no. 6, pp. 493–499, 2004. View at Google Scholar · View at Scopus
  33. B. M. Mitchell and R. C. Webb, “Impaired vasodilation and nitric oxide synthase activity in glucocorticoid-induced hypertension,” Biological research for nursing, vol. 4, no. 1, pp. 16–21, 2002. View at Google Scholar · View at Scopus
  34. M. Baykan, C. Erem, Ö. Gedikli et al., “Impairment of flow-mediated vasodilatation of brachial artery in patients with Cushing's syndrome,” Endocrine, vol. 31, no. 3, pp. 300–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Albiger, R. M. Testa, B. Almoto et al., “Patients with Cushing's syndrome have increased intimal media thickness at different vascular levels: comparison with a population matched for similar cardiovascular risk factors,” Hormone and Metabolic Research, vol. 38, no. 6, pp. 405–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Kirilov, A. Tomova, L. Dakovska, P. Kumanov, A. Shinkov, and A. S. Alexandrov, “Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome,” European Journal of Endocrinology, vol. 149, no. 6, pp. 549–553, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Dovio, B. Allasino, E. Palmas et al., “Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 5, pp. 1803–1808, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Terzolo, B. Allasino, S. Bosio et al., “Hyperhomocysteinemia in patients with Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 3745–3751, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Rizzoni, E. Porteri, C. de Ciuceis et al., “Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 12, pp. 5010–5018, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. N. M. Neary, O. J. Booker, B. S. Abel et al., “Hypercortisolism is associated with increased coronary arterial atherosclerosis: analysis of noninvasive coronary angiography using multidetector computerized tomography,” Journal of Clinical Endocrinology and Metabolism, vol. 98, pp. 2045–2052, 2013. View at Google Scholar
  41. M. J. Barahona, E. Resmini, D. Viladés et al., “Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 98, pp. 1093–1099, 2013. View at Publisher · View at Google Scholar
  42. B. van Zaane, E. Nur, A. Squizzato et al., “Hypercoagulable state in Cushing's syndrome: a systematic review,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 8, pp. 2743–2750, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. L. M. Fatti, B. Bottasso, C. Invitti, R. Coppola, F. Cavagnini, and P. M. Mannucci, “Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome,” Journal of Endocrinological Investigation, vol. 23, no. 3, pp. 145–150, 2000. View at Google Scholar · View at Scopus
  44. A. Casonato, E. Pontara, M. Boscaro et al., “Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome,” Blood Coagulation and Fibrinolysis, vol. 10, no. 3, pp. 145–151, 1999. View at Google Scholar · View at Scopus
  45. M. Boscaro, N. Sonino, A. Scarda et al., “Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3662–3666, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. M. L. Muiesan, M. Lupia, M. Salvetti et al., “Left ventricular structural andnfunctional characteristics in Cushing's syndrome,” Journal of the American College of Cardiology, vol. 41, no. 12, pp. 2275–2279, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. F. Fallo, S. Budano, N. Sonino, M. L. Muiesan, E. Agabiti-Rosei, and M. Boscaro, “Left ventricular structural characteristics in Cushing's syndrome,” Journal of Human Hypertension, vol. 8, no. 7, pp. 509–513, 1994. View at Google Scholar · View at Scopus
  48. F. Fallo, P. Maffei, A. Dalla Pozza et al., “Cardiovascular autonomic function in Cushing's syndrome,” Journal of Endocrinological Investigation, vol. 32, no. 1, pp. 41–45, 2009. View at Google Scholar · View at Scopus
  49. A. Colao, R. Pivonello, S. Spiezia et al., “Persistence of increased cardiovascular risk in patients with cushing's disease after five years of successful cure,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 8, pp. 2664–2672, 1999. View at Google Scholar · View at Scopus
  50. G. Arnaldi, T. Mancini, B. Polenta, and M. Boscaro, “Cardiovascular risk in Cushing's syndrome,” Pituitary, vol. 7, no. 4, pp. 253–256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Tauchmanovà, R. Rossi, B. Biondi et al., “Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 11, pp. 4872–4878, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. S. M. Webb, D. Mo, S. W. J. Lamberts et al., “Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing's disease or non-functioning pituitary adenoma,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 2, pp. 630–638, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. F. Fallo, G. Famoso, D. Capizzi et al., “Coronary microvascular function in patients with Cushing's syndrome,” Endocrine, vol. 43, no. 1, pp. 206–213, 2013. View at Google Scholar
  54. J. A. Whitworth, P. M. Williamson, G. Mangos, and J. J. Kelly, “Cardiovascular consequences of cortisol excess,” Vascular health and risk management, vol. 1, no. 4, pp. 291–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. J. M. C. Connell, J. A. Whitworth, and D. L. Davies, “Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man,” Journal of Hypertension, vol. 5, no. 4, pp. 425–433, 1987. View at Google Scholar · View at Scopus
  56. B. Catargi, V. Rigalleau, A. Poussin et al., “Occult Cushing's syndrome in type-2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5808–5813, 2003. View at Publisher · View at Google Scholar · View at Scopus
  57. E. Resmini, F. Minuto, A. Colao, and D. Ferone, “Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities,” Acta Diabetologica, vol. 46, no. 2, pp. 85–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. C. Giordano, V. Guarnotta, R. Pivonello et al., “Is Diabetes in Cushing syndrome only a consequence of hypercortisolism?” European Journal of Endocrinology, vol. 170, pp. 313–321, 2013. View at Google Scholar
  59. M. R. Taskinen, E. A. Nikkila, R. Pelkonen, and T. Sane, “Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 57, no. 3, pp. 619–626, 1983. View at Google Scholar · View at Scopus
  60. K. J. Melanson, K. J. McInnis, J. M. Rippe, G. Blackburn, P. F. Wilson, and M. D. Cheitlin, “Obesity and cardiovascular disease risk: research update,” Cardiology in Review, vol. 9, no. 4, pp. 202–207, 2001. View at Google Scholar · View at Scopus
  61. M. J. Barahona, E. Resmini, N. Sucunza, and S. M. Webb, “Diagnosis of cure in Cushing's syndrome: lessons from long-term follow-up,” Frontiers of Hormone Research, vol. 38, pp. 152–157, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. National Cholesterol Education Program (NCEP) Expert Panel, “Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report,” Circulation, vol. 106, pp. 3143–3421, 2002. View at Google Scholar
  63. M. J. Barahona, N. Sucunza, E. Resmini et al., “Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3365–3371, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. B. Kola, M. Christ-Crain, F. Lolli et al., “Changes in adenosine 5′-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 12, pp. 4969–4973, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. M. G. Burt, J. Gibney, and K. K. Y. Ho, “Characterization of the metabolic phenotypes of Cushing's syndrome and growth hormone deficiency: a study of body composition and energy metabolism,” Clinical Endocrinology, vol. 64, no. 4, pp. 436–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. T. Ueland, C. Kristo, K. Godang, P. Aukrust, and J. Bollerslev, “Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1492–1496, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Pirlich, H. Biering, H. Gerl et al., “Loss of body cell mass in Cushing's syndrome: effect of treatment,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 3, pp. 1078–1084, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. V. Abad, G. P. Chrousos, J. C. Reynolds et al., “Glucocorticoid excess during adolescence leads to a major persistent deficit in bone mass and an increase in central body fat,” Journal of Bone and Mineral Research, vol. 16, no. 10, pp. 1879–1885, 2001. View at Google Scholar · View at Scopus
  69. G. M. Leong, V. Abad, E. Charmandari et al., “The effects of child-and adolescent-onset endogenous Cushing syndrome on bone mass, body composition and growth: a 7-year prospective study into young adulthood,” Journal of Bone and Mineral Research, vol. 16, pp. 1879–1885, 2006. View at Google Scholar
  70. P. M. Stewart, “Tissue-specific Cushing's syndrome, 11-β-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action,” European Journal of Endocrinology, vol. 149, no. 3, pp. 163–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  71. J. W. Tomlinson, E. A. Walker, I. J. Bujalska et al., “11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response,” Endocrine Reviews, vol. 25, no. 5, pp. 831–866, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. I. J. Bujalska, S. Kumar, and P. M Stewart, “Does central obesity reflect ‘Cushing's disease of the omentum’?” The Lancet, vol. 349, no. 9060, pp. 1210–1213, 1997. View at Google Scholar · View at Scopus
  73. G. P. Chrousos, “The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: Neuro-endocrine and target tissue-related causes,” International Journal of Obesity, vol. 24, supplement 2, pp. S50–S55, 2000. View at Publisher · View at Google Scholar · View at Scopus
  74. R. Rosmond and P. Björntorp, “Occupational status, cortisol secretory pattern, and visceral obesity in middle-aged men,” Obesity Research, vol. 8, no. 6, pp. 445–450, 2000. View at Google Scholar · View at Scopus
  75. P. Anagnostis, V. G. Athyros, K. Tziomalos, A. Karagiannis, and D. P. Mikhailidis, “The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 8, pp. 2692–2701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. E. Canalis and A. Giustina, “Glucocorticoid-induced osteoporosis: summary of a workshop,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5681–5685, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. I. Chiodini, M. Torlontano, V. Carnevale, V. Trischitta, and A. Scillitani, “Skeletal involvement in adult patients with endogenous hypercortisolism,” Journal of Endocrinological Investigation, vol. 31, no. 3, pp. 267–276, 2008. View at Google Scholar · View at Scopus
  78. T. Mancini, M. Doga, G. Mazziotti, and A. Giustina, “Cushing's syndrome and bone,” Pituitary, vol. 7, no. 4, pp. 243–246, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. J. L. Shaker and B. P. Lukert, “Osteoporosis associated with excess glucocorticoids,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 341–356, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. C. Kristo, R. Jemtland, T. Ueland, K. Godang, and J. Bollerslev, “Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study,” European Journal of Endocrinology, vol. 154, no. 1, pp. 109–118, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. P. J. Manning, M. C. Evans, and I. R. Reid, “Normal bone mineral density following cure of Cushing's syndrome,” Clinical Endocrinology, vol. 36, no. 3, pp. 229–234, 1992. View at Google Scholar · View at Scopus
  82. P. Vestergaard, J. Lindholm, J. O. L. Jørgensen et al., “Increased risk of osteoporotic fractures in patients with Cushing's syndrome,” European Journal of Endocrinology, vol. 146, no. 1, pp. 51–56, 2002. View at Google Scholar · View at Scopus
  83. C. di Somma, R. Pivonello, S. Loche et al., “Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study,” Clinical Endocrinology, vol. 58, no. 3, pp. 302–308, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. A. R. Hermus, A. G. Smals, L. M. Swinkels et al., “Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 10, pp. 2856–2865, 1995. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Faggiano, R. Pivonello, M. Filippella et al., “Spine abnormalities and damage in patients cured from Cushing's disease,” Pituitary, vol. 4, no. 3, pp. 153–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  86. M. J. Barahona, N. Sucunza, E. Resmini et al., “Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome,” Journal of Bone and Mineral Research, vol. 24, no. 11, pp. 1841–1846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. W. Arlt, C. Rosenthal, S. Hahner, and B. Allolio, “Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements,” Clinical Endocrinology, vol. 64, no. 4, pp. 384–389, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. M. Minetto, G. Reimondo, G. Osella, M. Ventura, A. Angeli, and M. Terzolo, “Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome,” Osteoporosis International, vol. 15, no. 11, pp. 855–861, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. N. Ohmori, K. Nomura, K. Ohmori, Y. Kato, T. Itoh, and K. Takano, “Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome,” Endocrine Journal, vol. 50, no. 1, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. L. Tauchmanovà, R. Pivonello, C. D. Somma et al., “Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 5, pp. 1779–1784, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. N. Karavitaki, G. Ioannidis, F. Giannakopoulos, P. Mavrokefalos, and N. Thalassinos, “Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome,” Clinical Endocrinology, vol. 60, no. 2, pp. 264–270, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. I. Chiodini, V. Carnevale, M. Torlontano et al., “Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 6, pp. 1863–1867, 1998. View at Publisher · View at Google Scholar · View at Scopus
  93. I. Bourdeau, C. Bard, H. Forget, Y. Boulanger, H. Cohen, and A. Lacroix, “Cognitive function and cerebral assessment in patients who have Cushing's syndrome,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 357–369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Bourdeau, C. Bard, B. Noël et al., “Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 1949–1954, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. N. E. Simmons, H. M. Do, M. H. Lipper, and E. R. Laws Jr., “Cerebral atrophy in Cushing's disease,” Surgical Neurology, vol. 53, no. 1, pp. 72–76, 2000. View at Publisher · View at Google Scholar · View at Scopus
  96. Z. Gnjidić, T. Sajko, N. Kudelié et al., “Reversible “brain atrophy” in patients with Cushing's disease,” Collegium Antropologicum, vol. 32, no. 4, pp. 1165–1170, 2008. View at Google Scholar · View at Scopus
  97. S. J. Lupien and M. Lepage, “Stress, memory, and the hippocampus: can't live with it, can't live without it,” Behavioural Brain Research, vol. 127, no. 1-2, pp. 137–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. R. S. Sloviter, A. L. Sollas, E. Dean, and S. Neubort, “Adrenalectomy-induced granule cell degeneration in the rat hippocampal dentate gyrus: characterization of an in vivo model of controlled neuronal death,” Journal of Comparative Neurology, vol. 330, no. 3, pp. 324–336, 1993. View at Google Scholar · View at Scopus
  99. R. M. Sapolsky, B. A. Stein-Behrens, and M. P. Armanini, “Long-term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus,” Experimental Neurology, vol. 114, no. 2, pp. 246–249, 1991. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Watanabe, E. Gould, and B. S. McEwen, “Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons,” Brain Research, vol. 588, no. 2, pp. 341–345, 1992. View at Publisher · View at Google Scholar · View at Scopus
  101. H. Uno, R. Tarara, J. G. Else, M. A. Suleman, and R. M. Sapolsky, “Hippocampal damage associated with prolonged and fatal stress in primates,” Journal of Neuroscience, vol. 9, no. 5, pp. 1705–1711, 1989. View at Google Scholar · View at Scopus
  102. R. M. Sapolsky, H. Uno, C. S. Rebert, and C. E. Finch, “Hippocampal damage associated with prolonged glucocorticoid exposure in primates,” Journal of Neuroscience, vol. 10, no. 9, pp. 2897–2902, 1990. View at Google Scholar · View at Scopus
  103. V. Luine, M. Villegas, C. Martinez, and B. S. McEwen, “Repeated stress causes reversible impairments of spatial memory performance,” Brain Research, vol. 639, no. 1, pp. 167–170, 1994. View at Publisher · View at Google Scholar · View at Scopus
  104. M. N. Starkman, B. Giordani, S. S. Gebarski, S. Berent, M. A. Schork, and D. E. Schteingart, “Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease,” Biological Psychiatry, vol. 46, no. 12, pp. 1595–1602, 1999. View at Publisher · View at Google Scholar · View at Scopus
  105. M. N. Starkman, B. Giordani, S. S. Gebarski, and D. E. Schteingart, “Improvement in mood and ideation associated with increase in right caudate volume,” Journal of Affective Disorders, vol. 101, no. 1–3, pp. 139–147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  106. D. P. Merke, J. N. Giedd, M. F. Keil et al., “Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2531–2536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  107. F. S. Maheu, L. Mazzone, D. P. Merke et al., “Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of Cushing syndrome,” Development and Psychopathology, vol. 20, no. 4, pp. 1177–1189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. M. N. Starkman, S. S. Gebarski, S. Berent, and D. E. Schteingart, “Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome,” Biological Psychiatry, vol. 32, no. 9, pp. 756–765, 1992. View at Publisher · View at Google Scholar · View at Scopus
  109. E. Resmini, A. Santos, B. Gómez-Anson et al., “Verbal and visual memory performance and hippocampal volumes, measured by 3-tesla magnetic resonance imaging, in patients with Cushing's syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 2, pp. 663–671, 2012. View at Publisher · View at Google Scholar · View at Scopus
  110. E. Resmini, A. Santos, B. Gómez-Anson et al., “Hippocampal dysfunction in cured Cushing's syndrome patients, detected by 1H-MR-spectroscopy,” Clinical Endocrinology, vol. 79, pp. 700–707, 2013. View at Google Scholar
  111. N. Sonino and G. A. Fava, “Psychiatric disorders associated with Cushing's syndrome: epidemiology, pathophysiology and treatment,” CNS Drugs, vol. 15, no. 5, pp. 361–373, 2001. View at Google Scholar · View at Scopus
  112. M. N. Starkman, D. E. Schteingart, and M. A. Schork, “Depressed mood and other psychiatric manifestations of Cushing's syndrome: Relationship to hormone levels,” Psychosomatic Medicine, vol. 43, no. 1, pp. 3–18, 1981. View at Google Scholar · View at Scopus
  113. N. Sonino and G. A. Fava, “Psychosomatic aspects of Cushing's disease,” Psychotherapy and Psychosomatics, vol. 67, no. 3, pp. 140–146, 1998. View at Publisher · View at Google Scholar · View at Scopus
  114. W. F. Kelly, M. J. Kelly, and B. Faragher, “A prospective study of psychiatric and psychological aspects of Cushing's syndrome,” Clinical Endocrinology, vol. 45, no. 6, pp. 715–720, 1996. View at Google Scholar · View at Scopus
  115. L. D. Dorn, E. S. Burgess, T. C. Friedman, B. Dubbert, P. W. Gold, and G. P. Chrousos, “The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 3, pp. 912–919, 1997. View at Publisher · View at Google Scholar · View at Scopus
  116. N. Sonino, S. Bonnini, F. Fallo, M. Boscaro, and G. A. Fava, “Personality characteristics and quality of life in patients treated for Cushing's syndrome,” Clinical Endocrinology, vol. 64, no. 3, pp. 314–318, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. I. Bourdeau, C. Bard, H. Forget, Y. Boulanger, H. Cohen, and A. Lacroix, “Cognitive function and cerebral assessment in patients who have Cushing's syndrome,” Endocrinology and Metabolism Clinics of North America, vol. 34, no. 2, pp. 357–369, 2005. View at Publisher · View at Google Scholar · View at Scopus
  118. H. Forget, A. Lacroix, M. Somma, and H. Cohen, “Cognitive decline in patients with Cushing's syndrome,” Journal of the International Neuropsychological Society, vol. 6, no. 1, pp. 20–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  119. T. B. Whelan, D. E. Schteingart, M. N. Starkman, and A. Smith, “Neuropsychological deficits in Cushing's syndrome,” Journal of Nervous and Mental Disease, vol. 168, no. 12, pp. 753–757, 1980. View at Google Scholar · View at Scopus
  120. P. M. Gotch, “Cushing's syndrome from the patient's perspective,” Endocrinology and Metabolism Clinics of North America, vol. 23, pp. 607–617, 1994. View at Google Scholar
  121. M. Mauri, E. Sinforiani, G. Bono et al., “Memory impairment in Cushing's disease,” Acta Neurologica Scandinavica, vol. 87, no. 1, pp. 52–55, 1993. View at Google Scholar · View at Scopus
  122. M. N. Starkman, B. Giordani, S. Berent, M. A. Schork, and D. E. Schteingart, “Elevated cortisol levels in Cushing's disease are associated with cognitive decrements,” Psychosomatic Medicine, vol. 63, no. 6, pp. 985–993, 2001. View at Google Scholar · View at Scopus
  123. J. León-Carrión, A. M. Atutxa, M. A. Mangas et al., “A clinical profile of memory impairment in humans due to endogenous glucocorticoid excess,” Clinical Endocrinology, vol. 70, no. 2, pp. 192–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. K. Michaud, H. Forget, and H. Cohen, “Chronic glucocorticoid hypersecretion in Cushing's syndrome exacerbates cognitive aging,” Brain and Cognition, vol. 71, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  125. E. Martignoni, A. Costa, E. Sinforiani et al., “The brain as a target for adrenocortical steroids: cognitive implications,” Psychoneuroendocrinology, vol. 17, no. 4, pp. 343–354, 1992. View at Publisher · View at Google Scholar · View at Scopus
  126. M. N. Starkman, B. Giordani, S. S. Gebarski, and D. E. Schteingart, “Improvement in learning associated with increase in hippocampal formation volume,” Biological Psychiatry, vol. 53, no. 3, pp. 233–238, 2003. View at Publisher · View at Google Scholar · View at Scopus
  127. L. D. Dorn and P. Cerrone, “Cognitive function in patients with Cushing's syndrome: a longitudinal perspective,” Clinical Nursing Research, vol. 9, pp. 420–440, 2000. View at Google Scholar
  128. H. Forget, A. Lacroix, and H. Cohen, “Persistent cognitive impairment following surgical treatment of Cushing's syndrome,” Psychoneuroendocrinology, vol. 27, no. 3, pp. 367–383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  129. J. Tiemensma, N. E. Kokshoorn, N. R. Biermasz et al., “Subtle cognitive impairments in patients with long-term cure of Cushing's disease,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2699–2714, 2010. View at Publisher · View at Google Scholar · View at Scopus
  130. J. R. Lindsay, T. Nansel, S. Baid, J. Gumowski, and L. K. Nieman, “Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 2, pp. 447–453, 2006. View at Publisher · View at Google Scholar · View at Scopus
  131. M. T. Hawn, D. Cook, C. Deveney et al., “Quality of life after laparoscopic bilateral adrenalectomy for Cushing's disease,” Surgery, vol. 132, no. 6, pp. 1064–1068, 2002. View at Publisher · View at Google Scholar · View at Scopus
  132. A. Santos, E. Resmini, M. A. Martínez, C. Martí, J. Ybarra, and S. M. Webb, “Quality of life in patients with pituitary tumors,” Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, pp. 299–303, 2009. View at Publisher · View at Google Scholar
  133. M. D. Johnson, C. J. Woodburn, and M. Lee Vance, “Quality of life in patients with a pituitary adenoma,” Pituitary, vol. 6, no. 2, pp. 81–87, 2003. View at Publisher · View at Google Scholar · View at Scopus
  134. S. M. Webb, X. Badia, M. J. Baarahona et al., “Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire,” European Journal of Endocrinology, vol. 158, no. 5, pp. 623–630, 2008. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Santos, E. Resmini, M. A. Martínez-Momblán et al., “Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice,” European Journal of Endocrinology, vol. 167, pp. 337–342, 2012. View at Google Scholar
  136. J. Tiemensma, A. A. Kaptein, A. M. Pereira, J. W. A. Smit, J. A. Romijn, and N. R. Biermasz, “Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome,” European Journal of Endocrinology, vol. 165, no. 4, pp. 527–535, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. J. Lindholm, S. Juul, J. O. L. Jørgensen et al., “Incidence and late prognosis of Cushing's syndrome: a population-based study,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 1, pp. 117–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  138. A. Faggiano, R. Pivonello, S. Spiezia et al., “Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 6, pp. 2527–2533, 2003. View at Google Scholar · View at Scopus
  139. F. Fallo, N. Sonino, L. Barzon et al., “Effect of surgical treatment on hypertension in Cushing's syndrome,” The American Journal of Hypertension, vol. 9, no. 1, pp. 77–80, 1996. View at Publisher · View at Google Scholar · View at Scopus
  140. F. Fallo and N. Sonino, “Should we evaluate for cardiovascular disease in patients with cushing's syndrome?” Clinical Endocrinology, vol. 71, no. 6, pp. 768–771, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. E. Resmini, C. Farkas, B. Murillo et al., “Body composition after endogenous (Cushing's syndrome) and exogenous (rheumatoid arthritis) exposure to glucocorticoids,” Hormone and Metabolic Research, vol. 42, no. 8, pp. 613–618, 2010. View at Publisher · View at Google Scholar · View at Scopus